Cargando…

Review of the efficacy of AST-120 (KREMEZIN(®)) on renal function in chronic kidney disease patients

AST-120 (KREMEZIN®) consists of oral, spherical carbon particles that adsorb uremic toxins and their precursors within the gastrointestinal tract, allowing them to be excreted in the feces. Uremic toxins such as indoxyl sulfate and p-cresyl sulfate are abundant in the blood of chronic kidney disease...

Descripción completa

Detalles Bibliográficos
Autores principales:	Asai, Mayumi, Kumakura, Sei, Kikuchi, Mami
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2019
Materias:	State of the Art Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374968/ https://www.ncbi.nlm.nih.gov/pubmed/30732506 http://dx.doi.org/10.1080/0886022X.2018.1561376

Ejemplares similares

Importance of AST-120 (Kremezin®) Adherence in a Chronic Kidney Disease Patient with Diabetes
por: Tomino, Yasuhiko, et al.
Publicado: (2018)

Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120
por: Schulman, Gerald, et al.
Publicado: (2017)

AST-120 for the management of progression of chronic kidney disease
por: Schulman, Gerald, et al.
Publicado: (2014)

Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options
por: Jankowski, Joachim, et al.
Publicado: (2021)

A systemic review and meta-analysis on the efficacy and safety of ferumoxytol for anemia in chronic kidney disease patients
por: Zuo, Qianwei, et al.
Publicado: (2022)

The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trials
por: Schulman, Gerald, et al.
Publicado: (2016)

Aspirin at 120: Retiring, recombining, or repurposing?
por: Patrono, Carlo, et al.
Publicado: (2021)

Biomarker for early renal microvascular and diabetic kidney diseases
por: Futrakul, Narisa, et al.
Publicado: (2017)

Advance of autophagy in chronic kidney diseases
por: Deng, Xu, et al.
Publicado: (2017)

Efficacy of AST-120 for Patients With Chronic Kidney Disease: A Network Meta-Analysis of Randomized Controlled Trials
por: Su, Pei-Yu, et al.
Publicado: (2021)

Untargeted plasma and tissue metabolomics in rats with chronic kidney disease given AST-120
por: Velenosi, Thomas J., et al.
Publicado: (2016)

Targeting Vascular Calcification in Chronic Kidney Disease
por: Nelson, Adam J., et al.
Publicado: (2020)

An updated meta-analysis on the efficacy and safety of hypoxia-inducible factor prolyl hydroxylase inhibitor treatment of anemia in nondialysis-dependent chronic kidney disease
por: Zhao, Hanxue, et al.
Publicado: (2023)

The research status and prospect of Periostin in chronic kidney disease
por: Jia, Yuan-yuan, et al.
Publicado: (2020)

A Proposal for Integrated Efficacy-to-Effectiveness (E2E) Clinical Trials
por: Selker, H P, et al.
Publicado: (2014)

Epidemiology and treatment of depression in patients with chronic medical illness
por: J. Katon, Wayne.
Publicado: (2011)

Specific alterations in gut microbiota in patients with chronic kidney disease: an updated systematic review
por: Zhao, Jin, et al.
Publicado: (2021)

Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease
por: Halpin, David M. G., et al.
Publicado: (2021)

Critical Analysis of the Effects of SGLT2 Inhibitors on Renal Tubular Sodium, Water and Chloride Homeostasis and Their Role in Influencing Heart Failure Outcomes
por: Packer, Milton, et al.
Publicado: (2023)

Acquired long QT syndrome in chronic kidney disease patients
por: Liu, Peng, et al.
Publicado: (2019)

Advances in oxidative stress in pathogenesis of diabetic kidney disease and efficacy of TCM intervention
por: Ma, Xiaoju, et al.
Publicado: (2023)

Effect of an Oral Adsorbent, AST-120, on Dialysis Initiation and Survival in Patients with Chronic Kidney Disease
por: Hatakeyama, Shingo, et al.
Publicado: (2012)

Effect of magnesium on vascular calcification in chronic kidney disease patients: a systematic review and meta-analysis
por: Zhan, Ya, et al.
Publicado: (2023)

Structure and function of complex brain networks
por: Sporns, Olaf
Publicado: (2013)

Vascular Calcification in Chronic Kidney Disease: Distinct Features of Pathogenesis and Clinical Implication
por: Kim, Jin Sug, et al.
Publicado: (2021)

Role of abnormal energy metabolism in the progression of chronic kidney disease and drug intervention
por: Liu, Xuyan, et al.
Publicado: (2022)

Cerebral aging: integration of brain and behavioral models of cognitive function
por: Park, Denise C., et al.
Publicado: (2001)

Issues and developments related to assessing function in serious mental illness
por: Brown, Matt A., et al.
Publicado: (2016)

Subfractions of high-density lipoprotein (HDL) and dysfunctional HDL in chronic kidney disease patients
por: Rysz-Górzyńska, Magdalena, et al.
Publicado: (2016)

Pro- and anti-fibrotic effects of vascular endothelial growth factor in chronic kidney diseases
por: Miao, Changxiu, et al.
Publicado: (2022)

Targeting BCL2 With BH3 Mimetics: Basic Science and Clinical Application of Venetoclax in Chronic Lymphocytic Leukemia and Related B Cell Malignancies
por: Roberts, AW, et al.
Publicado: (2016)

Epilepsy research: a window onto function and dysfunction of the human brain
por: Beck, Heinz, et al.
Publicado: (2008)

Pharmacogenomic Discovery to Function and Mechanism: Breast Cancer as a Case Study
por: Wang, Liewei, et al.
Publicado: (2017)

Expanding on the use of The International Classification of Functioning, Disability and Health: Examples and resources
por: Maart, Soraya, et al.
Publicado: (2022)

Functional maturation of nasal mucosa: role of secretory immunoglobulin A (SIgA)
por: Bellussi, Luisa, et al.
Publicado: (2013)

Data-driven approaches for identifying links between brain structure and function in health and disease
por: Calhoun, Vincent
Publicado: (2018)

Calcitriol, calcidiol, parathyroid hormone, and fibroblast growth factor-23 interactions in chronic kidney disease
por: Brito Galvao, Joao F, et al.
Publicado: (2013)

Corticosteroid therapy versus physiotherapy on pain, mobility and function in shoulder impingement: A short note
por: Benjamin-Damons, Natalie, et al.
Publicado: (2022)

The effect of aerobic exercise on oxidative stress in patients with chronic kidney disease: a systematic review and meta-analysis with trial sequential analysis
por: Zhao, Mengjie, et al.
Publicado: (2023)

Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120
por: Liu, Wen-Chih, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_l362mdnr8sgfviip3p66rhpqfg